Growth opportunities Aqua actively pursues development, licensing, in-licensing, co-promotion, and acquisitions to expand its dermatology portfolio, presenting multiple partnership and product-acquisition avenues for external collaborators.

Dermatology focus Specialty US dermatology platform with an existing portfolio of prescription medicines and a strategy centered on skin conditions, creating a receptive environment for co-development or license deals in dermatology.

Strategic partner fits Almirall-backed backing provides stability and scale; potential partners can leverage Aqua’s market access and product development capabilities while tapping into Almirall’s broader R&D and distribution network.

Revenue potential Current revenue in the mid hundreds of millions signals a credible commercial footprint with room for accelerated growth through added products, co-promotion, and regional expansion opportunities.

Team continuity Recent leadership appointments and a defined growth strategy imply an active management focus on scaling, indicating a reliable customer-facing organization for new product introductions and partnerships.